{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T12:10:28Z","timestamp":1719749428823},"reference-count":20,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. braz j urol."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1590\/s1677-5538.ibju.2016.0622","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T06:24:05Z","timestamp":1515565445000},"page":"1122-1128","source":"Crossref","is-referenced-by-count":2,"title":["Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections"],"prefix":"10.1590","volume":"43","author":[{"given":"Maryam","family":"Emami","sequence":"first","affiliation":[{"name":"Iran University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pejman","family":"Shadpour","sequence":"additional","affiliation":[{"name":"Iran University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir H.","family":"Kashi","sequence":"additional","affiliation":[{"name":"Iran University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Choopani","sequence":"additional","affiliation":[{"name":"Iran University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Zeighami","sequence":"additional","affiliation":[{"name":"Iran University of Medical Sciences, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation subcommittee of the International Continence Society","volume":"61","author":"Abrams P","year":"2003","journal-title":"Urology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom I","year":"2001","journal-title":"BJU Int"},{"issue":"5A Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple CR","year":"2000","journal-title":"Urology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis","volume":"54","author":"Chapple CR","year":"2008","journal-title":"Eur Urol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski R","year":"2010","journal-title":"J Urol"},{"key":"ref6","first-page":"3291","article-title":"Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection","volume":"13","author":"Lucioni A","year":"2006","journal-title":"Can J Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","article-title":"Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux","volume":"177","author":"Karsenty G","year":"2007","journal-title":"J Urol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/nau.20515","article-title":"Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients","volume":"27","author":"Mascarenhas F","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.juro.2010.08.028","article-title":"Botulinum toxin-A injections into neurogenic overactive bladder\u2014to include or exclude the trigone? A prospective, randomized, controlled trial","volume":"184","author":"Abdel-Meguid TA","year":"2010","journal-title":"J Urol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.juro.2007.03.133","article-title":"Validation of the overactive bladder symptom score","volume":"178","author":"Blaivas JG","year":"2007","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei M","year":"2005","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","article-title":"Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity","volume":"54","author":"Kalsi V","year":"2008","journal-title":"Eur Urol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.eururo.2011.10.028","article-title":"Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study","volume":"61","author":"Denys P","year":"2012","journal-title":"Eur Urol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","article-title":"Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics","volume":"66","author":"Kuo HC","year":"2005","journal-title":"Urology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.eururo.2011.10.043","article-title":"Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity","volume":"61","author":"Manecksha RP","year":"2012","journal-title":"Eur Urol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"177","author":"Sahai A","year":"2007","journal-title":"J Urol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","article-title":"Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction","volume":"66","author":"Schulte-Baukloh H","year":"2005","journal-title":"Urology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00192-014-2499-2","article-title":"Trigonal versus extratrigonal botulinum toxin-A: a systematic review and meta-analysis of efficacy and adverse events","volume":"26","author":"Davis NF","year":"2015","journal-title":"Int Urogynecol J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/nau.21054","article-title":"Bladder base\/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics","volume":"30","author":"Kuo HC","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid DM","year":"2006","journal-title":"J Urol"}],"container-title":["International braz j urol"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ibju\/v43n6\/1677-5538-ibju-43-06-1122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T11:28:27Z","timestamp":1719746907000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-55382017000601122&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1677-55382017000601122"],"URL":"https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2016.0622","relation":{},"ISSN":["1677-6119"],"issn-type":[{"value":"1677-6119","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}